Keywords: immunogen, gets, 5m, milestone, biogen, biopharmaceuticals, company

ImmunoGen gets $1.5M milestone from Biogen

Article | 11 February 2008

ImmunoGen, a US biopharmaceuticals company that develops targeted anticancer therapeutics using its Tumor-Activated Prodrug technology, says that its partner, Biogen ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Biogen Idec

Go to company listing